EGFR and glioblastoma: Together with the heterogeneity within the tumor, the multiplicity of genetic abnormalities among the most important signaling pathways (such as EGFR, PI3K, Ras, IDH-1), and the recurrence due to the presence of stem cells makes GBM the most aggressive brain tumor with poor prognosis, and thus difficult to treat23,24.